Oncology (colorectal) screening, biochemical enzyme-linked immunosorbent assay (ELISA) of 3 plasma or serum proteins (teratocarcinoma derived growth factor-1 [TDGF-1, Cripto-1], carcinoembryonic antigen [CEA], extracellular matrix protein [ECM]), with demographic data (age, gender, CRC-screening compliance) using a proprietary algorithm and reported as likelihood of CRC or advanced adenomas
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $289.16 | $320.42 | $320.42 | |
BCBS
| Facility | $414.21 | $460.23 | $480.62 | |
Cigna
| Professional | $448.93 | $448.93 | $561.16 | |
United
| Professional | $136.76 | $390.75 | $563.58 |